Kurzfassung

A PHASE IV, POSTMARKETING, OPEN-LABEL, EXTENSION (ROLLOVER) STUDY OF VEMURAFENIB IN PATIENTS WITH BRAFV600 MUTATION-POSITIVE MALIGNANCIES PREVIOUSL Y ENROLLED IN AN ANTECEDENT VEMURAFENIB PROTOCOL